Shandong Weigao Group Medical Polymer Company Limited
SHWGF
$0.7477
$0.101615.73%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 287.26M | 276.28M | 264.81M | 273.80M | 284.20M |
| Total Depreciation and Amortization | 135.12M | 132.30M | 129.21M | 128.74M | 128.74M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.38M | 15.33M | 23.93M | 24.50M | 24.51M |
| Change in Net Operating Assets | -40.65M | -42.21M | -43.59M | -43.59M | -43.59M |
| Cash from Operations | 388.11M | 381.71M | 374.35M | 383.45M | 393.86M |
| Capital Expenditure | -83.34M | -86.61M | -89.55M | -89.55M | -89.55M |
| Sale of Property, Plant, and Equipment | 185.60K | 559.80K | 932.20K | 932.20K | 932.20K |
| Cash Acquisitions | -- | -2.99M | -5.98M | -5.98M | -5.98M |
| Divestitures | -- | 41.10K | 82.00K | 82.00K | 82.00K |
| Other Investing Activities | -70.45M | -96.51M | -122.46M | -110.71M | -99.16M |
| Cash from Investing | -153.61M | -185.52M | -216.97M | -205.22M | -193.67M |
| Total Debt Issued | 2.84B | 1.62B | 392.70M | 392.70M | 392.70M |
| Total Debt Repaid | -2.99B | -1.89B | -802.22M | -802.22M | -802.22M |
| Issuance of Common Stock | 7.07M | 3.54M | -- | -- | -- |
| Repurchase of Common Stock | -80.98M | -99.25M | -117.51M | -77.02M | -36.53M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -121.32M | -111.54M | -101.31M | -101.31M | -101.31M |
| Other Financing Activities | -501.77M | -207.80M | 86.16M | -446.51M | -979.18M |
| Cash from Financing | -222.22M | -192.63M | -162.38M | -233.22M | -306.06M |
| Foreign Exchange rate Adjustments | 7.77M | 2.85M | -2.08M | 739.30K | 3.63M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.05M | 6.42M | -7.08M | -54.26M | -102.24M |